Cost-Effectiveness Analysis of Paclitaxel + Carboplatin Vs. Alternative Combinations in the Treatment of Non-Small Cell Lung Cancer. FE 2006, 7 (2), 97-117. https://doi.org/10.7175/fe.v7i2.680.